ATA771975A - Verfahren zur herstellung von neuen kortikoiden - Google Patents

Verfahren zur herstellung von neuen kortikoiden

Info

Publication number
ATA771975A
ATA771975A AT771975A AT771975A ATA771975A AT A771975 A ATA771975 A AT A771975A AT 771975 A AT771975 A AT 771975A AT 771975 A AT771975 A AT 771975A AT A771975 A ATA771975 A AT A771975A
Authority
AT
Austria
Prior art keywords
producing new
new corticoids
corticoids
producing
new
Prior art date
Application number
AT771975A
Other languages
English (en)
Other versions
AT345485B (de
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ATA771975A publication Critical patent/ATA771975A/de
Application granted granted Critical
Publication of AT345485B publication Critical patent/AT345485B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0023Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
    • C07J5/003Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
    • C07J5/0038Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT771975A 1974-10-09 1975-10-09 Verfahren zur herstellung von neuen kortikoiden AT345485B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2448662A DE2448662C2 (de) 1974-10-09 1974-10-09 6α-Fluor-16α-methyl-1,4,8-pregnatrien-3,20-dion-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
ATA771975A true ATA771975A (de) 1978-01-15
AT345485B AT345485B (de) 1978-09-25

Family

ID=5928132

Family Applications (1)

Application Number Title Priority Date Filing Date
AT771975A AT345485B (de) 1974-10-09 1975-10-09 Verfahren zur herstellung von neuen kortikoiden

Country Status (20)

Country Link
US (1) US4008313A (de)
JP (1) JPS5163166A (de)
AT (1) AT345485B (de)
AU (1) AU507129B2 (de)
BE (1) BE834347A (de)
CA (1) CA1040191A (de)
CH (1) CH616435A5 (de)
CS (1) CS182294B2 (de)
DD (1) DD123328A5 (de)
DE (1) DE2448662C2 (de)
DK (1) DK138500C (de)
ES (1) ES441639A1 (de)
FR (1) FR2287232A1 (de)
GB (1) GB1527249A (de)
HU (1) HU173116B (de)
IE (1) IE42283B1 (de)
IL (1) IL48208A (de)
NL (1) NL7511831A (de)
SE (1) SE407580B (de)
SU (1) SU818488A3 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7802905A (nl) * 1977-04-21 1978-10-24 Hoffmann La Roche Werkwijze voor het bereiden van d-homosteroiden.
US8729108B2 (en) * 2008-06-17 2014-05-20 Christopher J Dannaker Waterborne topical compositions for the delivery of active ingredients such as azelaic acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2059310C3 (de) * 1970-11-28 1980-10-30 Schering Ag diese enthaltende Arzneimittel sowie Verfahren zu ihrer Herstellung
GB1440064A (en) * 1972-08-11 1976-06-23 Glaxo Lab Ltd Delta8-9- steroids of the pregnane series

Also Published As

Publication number Publication date
SU818488A3 (ru) 1981-03-30
ES441639A1 (es) 1977-04-01
NL7511831A (nl) 1976-04-13
DE2448662C2 (de) 1983-07-21
IL48208A0 (en) 1975-11-25
DK138500C (da) 1979-02-26
DD123328A5 (de) 1976-12-12
SE7511266L (sv) 1976-04-12
DK455275A (da) 1976-04-10
IE42283B1 (en) 1980-07-16
AU507129B2 (en) 1980-02-07
CA1040191A (en) 1978-10-10
US4008313A (en) 1977-02-15
SE407580B (sv) 1979-04-02
IE42283L (en) 1976-04-09
BE834347A (fr) 1976-04-09
AT345485B (de) 1978-09-25
AU8556875A (en) 1977-04-21
FR2287232B1 (de) 1980-05-09
HU173116B (hu) 1979-02-28
JPS5163166A (de) 1976-06-01
DK138500B (da) 1978-09-18
CS182294B2 (en) 1978-04-28
FR2287232A1 (fr) 1976-05-07
CH616435A5 (de) 1980-03-31
IL48208A (en) 1979-01-31
DE2448662A1 (de) 1976-04-22
GB1527249A (en) 1978-10-04

Similar Documents

Publication Publication Date Title
AT344890B (de) Verfahren zur herstellung von neuen 6-thiatetracyclinen
AT348693B (de) Verfahren zur herstellung von neuen decapeptidamidderivaten
AT337363B (de) Verfahren zur herstellung von neuen daunomycinanaloga
AT342769B (de) Verfahren zur herstellung von neuen 1-oxacephemen
AT344333B (de) Verfahren zur herstellung von neuen 8-thiomethylergolinen
AT348540B (de) Verfahren zur herstellung von neuen substituierten phenylguanidinen
AT345998B (de) Verfahren zur herstellung von neuen 18-methyl- 19-nor-20-keto-pregnanen
AT350529B (de) Verfahren zur herstellung von neuen acylaminophenylalkylaminen
AT345815B (de) Verfahren zur herstellung von neuen thiadiazolylimidazolidinonderivaten
ATA247775A (de) Verfahren zur herstellung von neuen acylureidocephalosporinen
AT343675B (de) Verfahren zur herstellung von neuen biguaniden
ATA428075A (de) Verfahren zur herstellung von neuen 1-aethyl-3a-metasubstituiertes-phenyl-decahydroisochinolinen
AT346311B (de) Verfahren zur herstellung von neuen polyenverbindungen
AT347935B (de) Verfahren zur herstellung von neuen 2-carbalk- oxyamino-5(6)-phenylsulfonyloxy-benzimidazolen
AT342590B (de) Verfahren zur herstellung von neuen 2-amino-6-dialkylaminodihydropyridinen
AT349140B (de) Verfahren zur herstellung von neuen cephalosporinen
AT341539B (de) Verfahren zur herstellung von neuen 3-amino-2beta-thiohydrazoazetidinonen
AT342046B (de) Verfahren zur herstellung von neuen n-benzylaminooxazolinen
AT349160B (de) Verfahren zur herstellung von neuen bufatrienolidrhamnosidaethern
AT348697B (de) Verfahren zur herstellung von neuen d- homosteroiden
AT345485B (de) Verfahren zur herstellung von neuen kortikoiden
AT346362B (de) Verfahren zur herstellung von neuen 3-alkyl-7- (omega-1)-oxoalkylxanthinen
AT343108B (de) Verfahren zur herstellung von neuen nitrofurylverbindungen
ATA548975A (de) Verfahren zur herstellung von neuen beta-acyloxycrotonsaureamid-n-sulfohalogeniden
AT355034B (de) Verfahren zur herstellung von neuen 3- acylamino-2-azetidinonderivaten